Related Experiment Video
Updated: Dec 30, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Inhibiting CtBP2 expression blocks development of esophageal squamous cell carcinoma through decreasing angiogenesis
Yun Jiang1,2, Jianle Chen3, Yongfeng Shao1
1Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province People's Hospital Nanjing 210029, Jiangsu, People's Republic of China.
Abstract:
The aim of this study is to explain the effects and mechanism of CtBP2 in the development of esophageal squamous cell carcinoma. In this study, we first evaluated CtBP2 protein expression of ESCC tumor and adjacent normal tissues by immunohistochemistry (IHC) and Western blot (WB) assay. Meanwhile, the number of vessels of ESCC and adjacent normal tissues were measured by immunofluorescence. In cell experiments, the effects of CtBP2 were evaluated by wound healing assay, flow cytometry detection, and EPC tube formation. The mechanisms of CtBP2 were investigated by immunofluorescence, qRT-PCR, WB, and EdU incorporation assay. In conclusion, CtBP2 inhibits ESCC in vitro and CtBP2 has a key role in the development of ESCC.
Insights
Carcinoma of the esophagus squamous cell (ESCC) development is influenced by CtBP2. This study found CtBP2 inhibits ESCC in vitro, highlighting its key role in ESCC progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Esophageal squamous cell carcinoma (ESCC) is a major global health concern.
- Understanding the molecular mechanisms driving ESCC development is crucial for targeted therapies.
Purpose of the Study:
- To elucidate the effects and underlying mechanisms of CtBP2 in esophageal squamous cell carcinoma (ESCC) development.
- To investigate the role of CtBP2 in ESCC progression and angiogenesis.
Main Methods:
- Immunohistochemistry (IHC) and Western blot (WB) were used to assess CtBP2 protein expression in ESCC tissues.
- Immunofluorescence was employed to quantify vascularization in ESCC.
- In vitro assays including wound healing, flow cytometry, and endothelial progenitor cell (EPC) tube formation were performed.
- Gene expression and cellular proliferation were analyzed using qRT-PCR and EdU incorporation assays.
Main Results:
- CtBP2 protein expression levels were evaluated in ESCC and adjacent normal tissues.
- CtBP2 was found to inhibit ESCC progression in vitro.
- The study identified CtBP2's role in angiogenesis and cell proliferation within ESCC models.
Conclusions:
- CtBP2 exhibits inhibitory effects on esophageal squamous cell carcinoma (ESCC) in vitro.
- CtBP2 plays a pivotal role in the development and progression of ESCC.
- Further research into CtBP2's mechanisms may offer novel therapeutic strategies for ESCC.
Related Concept Videos
Inhibition of Cdk Activity
Regulation of Angiogenesis and Blood Supply
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mitogens and the Cell Cycle
Cell Specific Gene Expression

